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Abstract
The ability to quantify cellular heterogeneity is a major advantage of single-cell technologies. However, statistical
methods often treat cellular heterogeneity as a nuisance. We present a novel method to characterize differences in
expression in the presence of distinct expression states within and among biological conditions. We demonstrate that
this framework can detect differential expression patterns under a wide range of settings. Compared to existing
approaches, this method has higher power to detect subtle differences in gene expression distributions that are more
complex than a mean shift, and can characterize those differences. The freely available R package scDD implements
the approach.
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Background
Coordinated gene expression is fundamental to an organ-
ism’s development and maintenance, and aberrations are
common in disease. Consequently, experiments to mea-
sure expression on a genome-wide scale are pervasive.
Themost common experiment involves the quantification
of mRNA transcript abundance averaged over a popu-
lation of thousands or millions of cells. These so-called
traditional, or bulk, RNA-seq experiments have proven
useful in a multitude of studies. However, because bulk
RNA-seq does not provide a measure of cell-specific
expression, many important signals go unobserved. A
gene that appears to be expressed at a relatively constant
level in a bulk RNA-seq experiment, for example, may
actually be expressed in sub-groups of cells at levels that
vary substantially (see Fig. 1).
Single-cell RNA-seq (scRNA-seq) facilitates the mea-
surement of genome-wide mRNA abundance in individ-
ual cells, and as a result, provides the opportunity to
study the extent of gene-specific expression heterogeneity
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within a biological condition, and the impact of changes
across conditions. Doing so is required for discovering
novel cell types [1, 2], for elucidating how gene expression
changes contribute to development [3–5], for understand-
ing the role of cell heterogeneity on the immune response
[6, 7] and cancer progression [6, 8–10], and for predict-
ing the response to chemotherapeutic agents [11–13].
Unfortunately, the statistical methods available for char-
acterizing gene-specific expression within a condition and
for identifying differences across conditions in scRNA-
seq are greatly limited, largely because they do not fully
accommodate the cellular heterogeneity that is prevalent
in single-cell data.
To identify genes with expression that varies across bio-
logical conditions in an scRNA-seq experiment, a num-
ber of early studies used methods from bulk RNA-seq
[4, 10, 12, 14, 15]. In general, the methods assume that
each gene has a latent level of expression within a biolog-
ical condition, and that measurements fluctuate around
that level due to biological and technical sources of vari-
ability. In other words, they assume that gene-specific
expression is well characterized by a unimodal distribu-
tion within a condition. Further, tests for differences in
expression to identify so-called differentially expressed
(DE) genes amount to tests for shifts in the unimodal dis-
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Fig. 1 Schematic of the presence of two cell states within a cell population that can lead to bimodal expression distributions. a Time series of the
underlying expression state of gene X in a population of unsynchronized single cells, which switches back and forth between a low and high state
with means μ1 and μ2, respectively. The color of cells at each time point corresponds to the underlying expression state. b Population of individual
cells shaded by expression state of gene X at a snapshot in time. c Histogram of the observed expression level of gene X for the cell population in (b)
tributions across conditions. A major drawback of these
approaches in the single-cell setting is that, due to both
biological and technical cell-to-cell variability, there is
often an abundance of cells for which a given gene’s
expression is unobserved [7, 16, 17] and, consequently,
unimodal distributions are insufficient.
To address this, a number of statistical methods
have been developed recently to accommodate bimodal-
ity in scRNA-seq data [17, 18]. In these mixture-
model based approaches, one component distribution
accommodates unobserved, or dropout, measurements
(which include zero and, optionally, thresholded low-
magnitude observations) and a second unimodal com-
ponent describes gene expression in cells where expres-
sion is observed. Although these approaches provide
an advance over unimodal models used in bulk, they
are insufficient for characterizing multi-modal expres-
sion data, which is common in scRNA-seq experiments
(see Fig. 2).
Specifically, a number of studies have shown that many
types of heterogeneity can give rise to multiple expression
modes within a given gene [19–23]. For example, there are
often multiple states among expressed genes [19, 20, 22]
(a schematic is shown in Fig. 1). The transition between
cell states may be primarily stochastic in nature and result
from expression bursts [24, 25], or result from positive
feedback signals [19, 23, 26]. Beyond the existence of mul-
tiple stable states, multiple modes in the distribution of
expression levels in a population of cells may also arise
when the gene is either oscillatory and unsynchronized, or
oscillatory with cellular heterogeneity in frequency, phase,
and amplitude [21, 23].
Figure 3 illustrates common multi-modal distributions
within and across biological conditions. When the over-
all mean expression level for a given gene is shifted across
conditions, then bulk methods, or recent methods for
scRNA-seq [17, 18, 27, 28], may be able to identify the
gene as showing some change. However, as we show here,
they would be relatively underpowered to do so, and they
would be unable to characterize the change, which is
often of interest in an scRNA-seq experiment. For exam-
ple, the gene in Fig. 3c shows a differential number of
modes (DM), while the gene in Fig. 3b shows a differ-
ential proportion (DP) of cells at each expression level
across conditions. Differentiating between DM and DP
is important since the former suggests the presence of
a distinct cell type in one condition, but not the other,
while the latter suggests a change in splicing patterns
among individual cells [7] or cell-specific responses to
signaling [29].
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Fig. 2 Comparison of modality in bulk versus single cells. Bar plot of the proportion of genes (or transcripts) in each dataset where the
log-transformed nonzero expression measurements are best fit by a 1, 2, or 3+ mode normal mixture model (where 3+ denotes 3 or more).
Modality is determined using a Bayesian information selection criterion with filtering (see “Partition estimation”). Red shades denote bulk RNA-seq
datasets, and blue shades denote single-cell datasets. The number following each dataset label indicates the number of samples present (e.g., GE.50
is a bulk dataset with 50 samples). Datasets GE.50, GE.75, and GE.100 are constructed by randomly sampling 50, 75, and 100 samples from GEUVADIS
[56]. Dataset LC consists of 77 normal samples from the TCGA lung adenocarcinoma study [57]. For details of the single-cell datasets, see “Methods”
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Fig. 3 Diagram of plausible differential distribution patterns (smoothed density histograms), including a traditional differential expression (DE), b
differential proportion of cells within each component (DP), c differential modality (DM), and d both differential modality and different component
means within each condition (DB). DB both differential modality and different component means, DE differential expression, DM differential
modality, DP differential proportion
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Here we develop a Bayesianmodeling framework, scDD,
to facilitate the characterization of expression within a
biological condition, and to identify genes with differential
distributions (DDs) across conditions in an scRNA-seq
experiment. A DD gene may be classified as DE, DM,
DP, or both DM and differential means of expression
states (abbreviated DB). Figure 3 provides an overview of
each pattern. Simulation studies suggest that the approach
provides improved power and precision for identifying
differentially distributed genes. Additional advantages are
demonstrated in a case study of human embryonic stem
cells (hESCs).
Results and discussion
Human embryonic stem cell data
scRNA-seq data were generated in the James Thomson
Lab at the Morgridge Institute for Research (see
“Methods” and [30] for details). Here we analyze data
from two undifferentiated hESC lines: the male H1 line
(78 cells) and the female H9 line (87 cells). In addition,
we include data from two differentiated cell types that are
both derived from H1: definitive endoderm cells (DECs,
64 cells) and neuronal progenitor cells (NPCs, 86 cells).
The relationship between these four cell types is summa-
rized by the diagram in Fig. 4. As discussed in the case
study results, it is of interest to characterize the differ-
ences in distributions of gene expression among these four
cell types to gain insight into the genes that regulate the
differentiation process.
Publicly available humanmyoblast andmouse embryonic
stem cell data
We also apply our method to two publicly available
scRNA-seq datasets to determine which genes are differ-
entially distributed following stimulation or inhibition of
differentiation via a specialized growth medium. Using
data from [31], we compare gene expression of human
myoblast cells cultured in standard growth medium (T0,
96 cells) with those treated with differentiation-inducing
medium for 72 hours (T72, 84 cells). Additionally, we
use data from [32] to compare the gene expression of
Undifferentiated 
Differentiated 
H1 
NPC DEC 
H9 
Fig. 4 Relationship of cell types used in hESC case study. H1 and H9
are undifferentiated hESC lines. NPC (neuronal progenitor cells) and
DEC (definitive endoderm cells) are differentiated cell types derived
from H1. DEC definitive endoderm cell, NPC neuronal progenitor cell
mouse embryonic stem cells (mESCs) cultured in stan-
dard medium (Serum + LIF, 93 cells) with those cultured
on differentiation-inhibiting medium (2i + LIF, 94 cells).
Simulated data
We evaluate model performance using log-transformed
count data simulated from mixtures of negative bino-
mial distributions. The analysis of log-transformed counts
from bulk RNA-seq has been shown to perform as well
as utilizing count-based modeling assumptions [33, 34].
Recent scRNA-seq analyses have also assumed the nor-
mality of log-transformed nonzero measurements [7, 18].
For each simulated dataset, 10,000 genes were simulated
for two conditions with four different sample size settings
(50, 75, 100, and 500 cells in each condition). The majority
of the genes (8000) were simulated out of the same model
in each condition, and the other 2000 represent genes with
the four types of DD outlined in Fig. 3. The 2000 DD genes
were split equally into the following four categories:
• DE: single component with a different mean in each
condition
• DP: two components in each condition with equal
component means across conditions; the proportion
in the low mode is 0.33 for condition 1 and 0.66 for
condition 2
• DM: single component in condition 1; two
components in condition 2 with one overlapping
component. Half of the condition 2 cells belong to
each mode
• DB: single component in condition 1; two
components in condition 2 with no overlapping
components. The mean of condition 1 is half-way
between the means in condition 2. Half of the cells in
condition 2 belong to each mode
Here a component represents the distribution of expres-
sion values at a particular expression level (or mode),
and different biological groups of interest are referred to
as conditions. Of the 8000 null genes, 4000 were gener-
ated from a single negative binomial component (EE, or
equivalent expression) and the other 4000 from a two-
component negative binomial mixture (EP, or equivalent
proportions of cells belonging to each component). The
parameters of the negative binomial distributions for the
unimodal genes were chosen to be representative of the
observed means and variances in the H1 dataset. Fold-
changes for DE genes were chosen to be representative of
those observed in the H1 and DEC comparison. Distances
between (log-scale) component means μσ (referred to
as component mean distance) in the multi-modal genes
were varied, with an equal proportion of genes at each
setting of μ ∈ {2, 3, 4, 5, 6}, where σ is the within-
component standard deviation on the log-scale (simulated
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to be common across components for a given gene and
condition). More details are provided in “Methods”.
The scDDmodeling framework
Let Yg = (yg1, . . . , ygJ ) be the log-transformed nonzero
expression measurements of gene g in a collection of
J cells from two biological conditions. We assume that
measurements have been normalized to adjust for tech-
nical sources of variation including amplification bias and
sequencing depth. Under the null hypothesis of equiva-
lent distributions (i.e., no dependence on condition), we
let Yg bemodeled by a conjugate Dirichlet processmixture
(DPM) of normals (see “Methods” for more details). Gene
g may also have expression measurements of zero in some
cells; these are modeled as a separate distributional com-
ponent (see “Differential proportion of zeroes” for more
details).
Ultimately, we would like to calculate a Bayes factor for
the evidence that the data arises from two independent
condition-specific models (DDs) versus one overall model
that ignores condition (equivalent distributions or EDs).
LetMDD denote the DD hypothesis, andMED denote the
equivalent distribution hypothesis. A Bayes factor in this
context for gene g would be:
BFg = f (Yg |MDD)f (Yg |MED)
where f (Yg |M) denotes the predictive distribution of the
observations from gene g under the given hypothesis.
In general, there is no analytical solution for this dis-
tribution under the DPM model framework. However,
under the product partition model (PPM) formulation
(see “Methods” for more details), we can get a closed form
solution for f (Yg ,Zg |M), where Zg represents a partition
(or clustering) of samples to mixture components. As the
partition Zg cannot be integrated out, we introduce an
approximate Bayes factor score:
Scoreg = log
( f (Yg ,Zg |MDD)
f (Yg ,Zg |MED)
)
= log
(
fC1(YC1g ,ZC1g )fC1(YC2g ,ZC2g )
fC1,C2(Yg ,Zg)
)
where C1 and C2 denote conditions 1 and 2, respectively,
and the score is evaluated at the partition estimate Zˆg . A
high value of this score presents evidence that a given gene
is differentially distributed. The significance of the score
is assessed via a permutation test. Specifically, condition
labels are permuted and partition estimates are obtained
within the new conditions. For each permuted dataset,
the Bayes factor score is calculated; the default in scDD is
1000 permutations. For each gene, an empirical p value is
calculated, and the false discovery rate (FDR) is controlled
for a given target value using the method of [35].
If covariates are available, instead of permuting the
observed values, the relationship between the clustering
and covariates can be preserved by permuting the residu-
als of a linear model that includes the covariate and using
the fitted values [36]. As pointed out by [18], the cellu-
lar detection rate is a potential confounder variable, so
the permutation procedure in the case studies is adjusted
in this manner. If other known confounders exist and are
measured, these can also be incorporated in the same
manner. Note that while this procedure adjusts for covari-
ates that affect mean expression levels, it does not adjust
for covariate-specific effects on variance. The sensitivity
of the approach to various levels of nonlinear confound-
ing effects is evaluated in a simulation study presented in
Additional file 1: Section 2.3.
Classification of significant DD genes
For genes that are identified as DD by the Bayes factor
score, of interest is classifying them into four categories
that represent the distinct DD patterns shown in Fig. 3.
To classify the DD genes into these patterns (DE, DM, DP,
and DB), scDD utilizes the conditional posterior distribu-
tion of the component-specific mean parameters given in
Eq. 6 (see “Methods”). Posterior sampling is carried out to
investigate the overlap of components across conditions.
Let c1 be the number of components in condition 1, c2 the
number of components in condition 2, and cOA the num-
ber of components overall (when pooling conditions 1
and 2). Only components containing at least three cells are
considered to minimize the impact of outlier cells. Note
that for interpretability, a DD gene must satisfy: c1 + c2 ≥
cOA ≥ min(c1, c2). These bounds on the overall number
of components represent the two extreme cases: condi-
tion 1 does not overlap with condition 2 at all, versus one
condition completely overlaps with the other. Any cases
outside of these boundaries are not readily interpretable
in this context. The actions to take for all other possible
combinations of c1, c2, and cOA are detailed in “Methods”.
Differential proportion of zeroes
For those genes that do not show DDs in the nonzero
values, scDD allows a user to evaluate whether the pro-
portion of zeroes differs significantly between the two
conditions. This evaluation is carried out using logistic
regression adjusted for the proportion of genes detected in
each cell as in [18]. Genes with a χ2 test p value of less than
0.025 (after adjustment for multiple comparisons using
the method of [35]) are considered to have a differential
proportion of zeroes (DZ).
Simulation study
A simulation study was conducted to assess the perfor-
mance of scDD in identifying DD genes, and to classify
them as DE, DP, DM, or DB. Model performance on the
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simulated data was assessed based on (1) the ability to esti-
mate the correct number of components, (2) the ability to
detect significantly DD genes, and (3) the ability to classify
DD genes into their correct categories. These three cri-
teria are explored in the next three sections, respectively.
Existingmethods for DE analysis are also evaluated for the
second criterion.
Estimation of the number of components
We first examine the ability of scDD to detect the correct
number of components. Table 1 displays the proportion of
bimodal and unimodal simulated genes where the correct
number of components was identified. For bimodal genes,
results are stratified by component mean distance. It is
clear that the ability of the algorithm to identify the cor-
rect number of components in bimodal genes improves
as the component mean distance or sample size increases.
The results for unimodal genes are not as sensitive to sam-
ple size; however, the proportion of genes identified as
bimodal increases slightly with more samples. We con-
clude that the partition estimate is able to detect reliably
the true number of components for reasonable sample and
effect sizes.
Detection of DD genes
Next, we examine the ability of scDD to identify the non-
null genes as significantly DD, and compare it to existing
methods, SCDE [17] and MAST [18]. For each method,
the target FDR was set at 5 % (see “Methods” for details).
The power to detect each gene pattern as DD for all three
methods is shown in Table 2. Note that the calculations
here are taken before the classification step for scDD, so
power is defined as the proportion of genes from each
simulated category that are detected as DD. In general, the
power to detect DD genes improves with increased sample
size for all three methods. Our approach has compara-
ble power to SCDE and MAST for DE and DP genes, but
higher overall power to detect DM and DB genes. Inter-
estingly, SCDE has very low power to detect DP genes,
whereas MAST shows very low power to detect DB genes.
Table 1 Rate of detection of correct number of components in
simulated data
Bimodal Unimodal
Sample component mean distance μ
size 2 3 4 5 6
50 0.056 0.196 0.579 0.848 0.922 0.907
75 0.052 0.252 0.719 0.917 0.957 0.908
100 0.050 0.302 0.811 0.950 0.974 0.905
500 0.073 0.417 0.959 0.995 0.991 0.884
Average proportion of simulated bimodal and unimodal genes where the correct
number of components was identified, averaged over gene category and condition.
Averages are calculated over 20 replications. Standard errors were <0.025 (not
shown)
Table 2 Power to detect DD genes in simulated data
True gene category
Sample size Method DE DP DM DB Overall (FDR)
50 scDD 0.893 0.418* 0.898* 0.572* 0.695* (0.029)
SCDE 0.872 0.026 0.817 0.260 0.494 (0.004)
MAST 0.908* 0.400 0.871 0.019 0.550 (0.026)
75 scDD 0.951 0.590 0.960* 0.668* 0.792* (0.031)
SCDE 0.948 0.070 0.903 0.387 0.577 (0.003)
MAST 0.956* 0.633* 0.943 0.036 0.642 (0.022)
100 scDD 0.972 0.717 0.982* 0.727* 0.850* (0.033)
SCDE 0.975 0.125 0.946 0.478 0.631 (0.003)
MAST 0.977* 0.752* 0.970 0.045 0.686 (0.022)
500 scDD 1.000* 0.983 1.000* 0.905* 0.972* (0.035)
SCDE 1.000* 0.855 0.998 0.787 0.910 (0.004)
MAST 1.000* 0.993* 1.000* 0.170 0.791 (0.022)
Average power to detect simulated DD genes by true category. Averages are
calculated over 20 replications. Standard errors were <0.025 (not shown)
DB both differential modality and different component means, DD differential
distribution, DE differential expression, DM differential modality, DP differential
proportion, FDR false discovery rate. Values followed by * designate which
method(s) achieved the highest power to detect DD genes from each particular
gene category (as well as overall) for each sample sample size setting
We note that SCDE andMAST do not aim to detect genes
with no change in the overall mean level in expressed cells
(as in the case of DB genes), so it is expected that scDD
will outperform other methods at detecting genes in this
category.
Classification of DD genes
Next, we examine the ability of scDD to classify each
DD gene into its corresponding category. Table 3 shows
the correct classification rate in each category for DD
genes that were correctly identified during the detection
step (calculated as the proportion of true positive genes
detected as DD for a given category that were classi-
fied into the correct category). The classification rates do
not depend strongly on sample size, with the exception
of DP, which decreases with increasing sample size. This
decrease results from an increase in the DD detection rate
of DP genes with small component mean distance, which
have a lower correct classification rate (as shown below).
Since the ability toclassify a DD gene correctly depends
on the ability to detect the correct number of compo-
nents (see classification algorithm in “Methods”), we also
examine how the correct classification rate varies with
component mean distance for the categories that con-
tain bimodal genes (DP, DM, and DB). As shown in
Table 4, the classification rates improve as μ increases.
This pattern mirrors the trend in Table 1, and suggests
that misclassification events occur largely due to incorrect
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Table 3 Correct classification rate in simulated data
Gene category
Sample size DE DP DM DB
50 0.719 0.801 0.557 0.665
75 0.760 0.732 0.576 0.698
100 0.782 0.678 0.599 0.706
500 0.816 0.550 0.583 0.646
Average correct classification rate for detected DD genes. Averages are calculated
over 20 replications. Standard errors were <0.025 (not shown)
DB both differential modality and different component means, DD differential
distribution, DE differential expression, DM differential modality, DP differential
proportion
estimation of the number of components. Performance
generally increases with sample size, especially at lower
values of μ. In general, the ability of the algorithm to
classify detected DD genes into their true category is
robust when components are well separated and improves
with increasing sample size.
Case study: identifying DD genes between hESC types
The comprehensive characterization of transcriptional
dynamics across hESC lines and derived cell types aims
to provide insight into the gene regulatory processes
governing pluripotency and differentiation [37–39]. Pre-
vious work utilizing microarrays and bulk RNA-seq
largely focused on identifying genes with changes in aver-
age expression level across a population of cells. By exam-
ining transcriptional changes at the single-cell level, we
Table 4 Average correct classification rates by component mean
distance
Sample size Gene category
Component mean distance μ
2 3 4 5 6
50 DP 0.02 0.20 0.78 0.94 0.98
DM 0.10 0.23 0.59 0.81 0.89
DB 0.08 0.22 0.59 0.80 0.80
75 DP 0.02 0.18 0.77 0.94 0.97
DM 0.08 0.27 0.69 0.86 0.90
DB 0.09 0.29 0.71 0.83 0.84
100 DP 0.03 0.16 0.74 0.93 0.95
DM 0.10 0.32 0.76 0.87 0.91
DB 0.08 0.32 0.80 0.85 0.84
500 DP 0.01 0.15 0.72 0.91 0.93
DM 0.12 0.33 0.72 0.85 0.89
DB 0.03 0.43 0.85 0.85 0.85
Average correct classification rates stratified by μ . Averages are calculated over 20
replications. Standard errors were <0.025 (not shown)
DB both differential modality and different component means, DM differential
modality, DP differential proportion
can uncover global changes that are undetectable when
averaging over the population. In addition, we gain the
ability to assess the level of heterogeneity of key dif-
ferentiation regulators, which may lead to the ability to
assess variation in pluripotency [40] or the differentiation
potential of individual cells.
The number of significant DD genes for each cell type
comparison is shown in Table 5 for scDD, SCDE, and
MAST. Note that the comparison of H1 and H9 detects
the fewest number of DD genes for all three methods, a
finding that is consistent with that both of these are undif-
ferentiated hESC lines and it is expected that they are the
most similar among the comparisons. In all four compar-
isons, the number of genes identified by our method is
greater than that for SCDE and similar to that for MAST.
Figure 5a displays top-ranked genes for each category
that are not identified by MAST or SCDE for the H1 ver-
sus DEC comparison. Among the genes identified exclu-
sively by scDD for the H1 versus DEC comparison are
CHEK2, a cell-cycle checkpoint kinase [41], and CDK7,
a cyclin-dependent kinase that plays a key role in cell-
cycle regulation through the activation of other cyclin-
dependent kinases [42]. It has been shown that embryonic
stem cells express cyclin genes constitutively, whereas in
differentiated cells, cyclin levels are oscillatory [43]. This
finding is consistent with the differential modality of the
CDK7 gene shown in Fig. 5b. Similarly, scDD identifies
several genes involved in the regulation of pluripotency
that are not identified by the other two methods (Fig. 5c).
For example, FOXP1 exhibits alternative splicing activity
in hESCs, stimulating expression of several key regula-
tors of pluripotency [44]. The PSMD12 gene encodes a
subunit of the proteasome complex that is vital to the
maintenance of pluripotency and has shown decreased
expression in differentiating hESCs [45]. Both of these
genes are also differentially distributed between H1 and
the other differentiated cell type, NPC.
In general, the vast majority of the genes found
exclusively by scDD are categorized as something other
Table 5 Number of DD genes identified in the hESC case study
data for scDD, SCDE, and MAST
scDD
Comparison DE DP DM DB DZ Total SCDE MAST
H1 vs NPC 1686 270 902 440 1603 5555 2921 5887
H1 vs DEC 913 254 890 516 911 5295 1616 3724
NPC vs DEC 1242 327 910 389 2021 5982 2147 5624
H1 vs H9 260 55 85 37 145 739 111 1119
Note that the total for scDD includes genes detected as DD but not categorized
DB both differential modality and different component means, DD differential
distribution, DE differential expression, DEC definitive endoderm cell, DM differential
modality, DP differential proportion, DZ differential zeroes, hESC human embryonic
stem cell, NPC neuronal progenitor cell
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Fig. 5 Violin plots (smoothed non-parametric kernel density
estimates) for Differentially Distributed genes identified between H1
and DEC. Individual observations are displayed with jitter. Within a
condition, points with the same shape are predicted to belong to the
same component. a scDD-exclusive genes: representative genes from
each category (DZ, DP, DM, and DB) that are not detected by MAST or
SCDE. Selected genes are top-ranked by permutation p value in each
category (DP, DM, and DB) or had a significant χ2 test for a difference
in the proportion of zeroes (DZ). b Cell-cycle genes: DD genes
involved in cell-cycle regulation (not detected by MAST or SCDE). c
Pluripotency genes: DD genes involved in pluripotency regulation
(not identified by MAST or SCDE). DB both differential modality and
different component means, DD differential distribution, DEC
definitive endoderm cell, DM differential modality, DP differential
proportion, DZ differential zeroes
than DE (ranging from 98.3 to 100 % in the three case
studies, see Additional file 1: Table S6), which suggests
that they are predominantly characterized by differences
that are more complex than the traditional DE pattern.
The genes identified by MAST but not scDD are over-
whelmingly characterized as those with a weak signal in
both the nonzero and zero components (see Additional
file 1: Figure S9), which can be difficult to interpret (see
Additional file 1: Section 3 for more details).
Additional case studies
We also applied scDD and MAST to two additional case
studies (the numbers of significant DD genes for each
comparison are displayed in Table 6). SCDE was not used
to analyze these datasets since it is intended for use on
raw count data and the processed data made available by
the authors of [31, 32] were already normalized by FPKM
and TPM, respectively. Like the results of the hESC case
study, MAST and scDD identify similar numbers of sig-
nificant genes. The genes that scDD finds exclusively are
predominantly characterized by something other than a
mean shift, a result which is also consistent with the hESC
case study (see Additional file 1: Table S7).
Advantages and limitations of the approach
We stress that our approach is inherently different from a
method that detects traditional DE, such as [17] and [18],
which aim to detect a shift in the mean of the expressed
values. In addition to identifying genes that have DDs
across conditions, our modeling framework allows us to
identify subpopulations within each condition that have
differing levels of expression of a given gene (i.e., which
cells belong to which component). For such genes, the par-
tition estimates automatically provide an estimate of the
proportion of cells in each condition that belong to each
subpopulation. We also do not require specification of
the total number of components, which can vary for each
gene.
When applied to cells at different differentiation stages,
this information may provide insight into which genes
are responsible for driving phenotypic changes. The gene
in Fig. 3b, for example, shows a DP of cells across
Table 6 Number of DD genes identified in the myoblast and
mESC case studies for scDD and MAST
scDD
Comparison DE DP DM DB DZ Total MAST
Myoblast: T0 vs T72 312 44 200 36 1311 2134 2904
mESC: Serum vs 2i 5233 76 1259 1128 670 9130 9706
Note that the total for scDD includes genes detected as DD but not categorized
DB both differential modality and different component means, DD differential
distribution, DE differential expression, DM differential modality, DP differential
proportion, DZ differential zeroes,mESC mouse embryonic stem cell
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conditions, which is important to recognize since DP
suggests a change in cell-specific responses to signaling
[7, 29]. This is in contrast to the DM gene in Fig. 3c,
which indicates the presence of a distinct cell type in one
condition, but not the other. Recent methods for scRNA-
seq [17, 18, 27, 28, 46] may be able to identify genes
such as those shown in Fig. 3b–d as differing between
conditions. However, our simulations suggest that they
would be relatively underpowered to do so, and they
would be unable to characterize the change as DP, DM,
or DB.
We also show through simulation that our approach can
accommodate large sample sizes of several hundreds of
cells per condition. Note, however, that the real strength in
the modeling framework lies in the ability to characterize
patterns of DDs. In the presence of extreme sparsity, this
will be a challenge, since the number of nonzero obser-
vations in a given gene will be small. If the sample size
of nonzero measurements is too small, it will be difficult
to infer the presence of multiple underlying cell states. In
practice, for larger and more sparse datasets, it is recom-
mended to verify that the number of cells expressing a
given gene is in the range of the sample sizes considered
in this study to utilize fully the available features of scDD.
The approach is limited in that adjustments for covari-
ates are not directly incorporated into the model. In
general, when the relationship between a potential con-
founding variable and the quantification of expression is
well known (e.g., increased sequencing depth is generally
associated with increased expression measurements), this
should be accounted for in a normalization procedure. For
other covariates that are not as well characterized (e.g., the
cellular detection rate and batch effects), residuals can be
used in the permutation procedure, though amore unified
approachwould be desirable.We also note thatmore com-
plex confounding variables may be present in scRNA-seq
experiments that are nonlinear in nature (e.g., covariate-
specific effects on variance). We show in Additional file 1:
Section 2.3 that when these effects are extreme, care must
be taken in interpreting DD genes that are uncategorized.
Additionally, the approach is limited in that only pair-
wise comparisons across biological conditions are fea-
sible. While an extended Bayes factor score to test for
the dependence of a condition on a partition estima-
tion for more than two conditions would be straightfor-
ward, the classification into meaningful patterns would
be less so, and work is underway in that direction.
Finally, we note that while the genes identified by
scDD may prove useful in downstream analysis, inter-
pretability is limited as partitions are estimated inde-
pendently for each gene and consequently do not pro-
vide a unified clustering of cells based on global gene
expression changes. Extensions in this direction are also
underway.
Conclusions
To our knowledge, we have presented the first statistical
method to detect differences in scRNA-seq experiments
that explicitly accounts for potential multi-modality of the
distribution of expressed cells in each condition. Such
multi-modal expression patterns are pervasive in scRNA-
seq data and are of great interest, since they represent
biological heterogeneity within otherwise homogeneous
cell populations; differences across conditions imply dif-
ferential regulation or response in the two groups. We
have introduced a set of five interesting patterns to sum-
marize the key features that can differ between two con-
ditions. Using simulation studies, we have shown that
our method has comparable performance to existing
methods when differences (mean shifts) exist between
unimodal distributions across conditions, and it outper-
forms existing approaches when there are more complex
differences.
Methods
Software implementations and applications
All analyses were carried out using R version 3.1.1 [47].
The method MAST [18] was implemented using the
MAST R package version 0.931, obtained from GitHub
at https://github.com/RGLab/MAST. The adjustment for
cellular detection rate as recommended in [18] was
included in the case study, but not in the simulation
study (only the normal component of the test was con-
sidered here since no difference in dropout rate was sim-
ulated). The method SCDE [17] was implemented using
the scde R package version 1.0, obtained from http://
pklab.med.harvard.edu/scde/index.html. No adjustment
for cellular detection rate was carried out since SCDE
cannot accommodate covariates. Since SCDE requires
raw integer counts as input, and expected counts are
non-integer valued, the ceiling function was applied to
the unnormalized counts. For each approach, the tar-
get FDR was controlled at 5 %. Specifically, both MAST
and SCDE provide gene-specific p values and use the
method of [35] to control FDR. We followed the same
procedure here.
Our method is implemented using version 1.1.0 of
the scDD R package, available at https://github.com/
kdkorthauer/scDD. The analysis involves a computa-
tionally intensive permutation step, which is executed
in parallel on multiple cores if available. On a Linux
machine using 12 cores and up to 16 gigabytes of mem-
ory, this step took approximately 60 minutes for 1000
permutations of 1000 genes in the simulation of 50 sam-
ples per condition. Computation time scales approxi-
mately linearly with sample size, and this same task takes
approximately 90 minutes for 100 samples per condition,
and 300 minutes for a sample size of 500 per condi-
tion. The computation time to analyze the simulated
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datasets for SCDE (MAST) ranged from approximately
3 to 30 (0.5 to 5) minutes across the different sample
sizes.
hESC culture and differentiation
All cell culture and scRNA-seq experiments were con-
ducted as described previously [30, 48]. Briefly, undif-
ferentiated H1 and H9 hESCs were routinely maintained
at the undifferentiated state in E8 medium on Matrigel
(BD Bioscience) coated tissue culture plates with daily
medium feeding [49]. HESCs were passaged every
3 to 4 days with 0.5 mM ethylenediaminetetraacetic
acid (EDTA) in phosphate-buffered saline (PBS) at
1:10 to 1:15 ratio for maintenance. H1 were differ-
entiated according to previously established protocols
[50, 51]. All the cell cultures performed in our laboratory
have been routinely tested as negative for mycoplasma
contamination.
For DECs, H1 cells were individualized with Accutase
(Life Technologies), seeded in E8 with BMP4 (5 ng/ml),
Activin A (25 ng/ml) and CHIR99021 (1 μM) for the
first 2 days, then withdraw CHIR99021 for the remain-
ing period of differentiation. DECs were harvested at the
end of day 5, and sorted for the CXCR4-positive popu-
lation for scRNA-seq experiments. For NPCs, the undif-
ferentiated H1-SOX2-mCherry reporter line was treated
with 0.5 mM EDTA in PBS for 3 to 5 min and seeded
in E6 (E8 minus FGF2, minus TGFβ1), with 2.5 μg/ml
insulin, SB431542 (10 μM) and 100 ng/ml Noggin. NPCs
were harvested and enriched at the end of day 7, after
sorting for the Cherry-positive population for scRNA-
seq experiments. All differentiation media were changed
daily.
Readmapping, quality control, and normalization
For each of the cell types studied, expected counts were
obtained from RSEM [52]. In each condition there are a
maximum of 96 cells, but all have fewer than 96 cells due
to removal by quality control standards. Some cells were
removed due to cell death or doublet cell capture, indi-
cated by a post cell capture image analysis as well as a very
low percentage of mapped reads. For more details on read
mapping and quality control, see [30, 48]. DESeq normal-
ization [53] was carried out using the MedianNorm func-
tion in the EBSeq R package [54] to obtain library sizes.
The library sizes were applied to scale the count data.
Further, genes with a very low detection rate (detected
in fewer than 25% of cells in either condition) are not
considered.
Publicly available scRNA-seq datasets
Processed FPKM-normalized data from human myoblast
cells [31] were obtained from GEO [55] using acces-
sion number GSE52529. In this study, we examined
the set of cells cultured on standard growth medium
(samples labeled with T0) as well as those treated
with differentiation-inducing medium for 72 h (sam-
ples labeled with T72). Processed TPM-normalized
data from mESCs [32] were also obtained from GEO
under accession number GSE60749. In this study, we
examined the samples labeled as mESC (cultured in
standard medium), along with the samples labeled as
TwoiLIF (cultured in 2i + LIF differentiation-inhibitory
medium).
Publicly available bulk RNA-seq datasets
The modality of the gene expression distributions in
bulk RNA-seq was explored using large, publicly avail-
able datasets and the results are displayed in Fig. 2.
In this figure, the red bars depict the bulk RNA-
seq results, and datasets are labeled according to their
source and sample size. Datasets GE.50, GE.75, and
GE.100 are constructed by randomly sampling 50, 75,
and 100 samples from GEUVADIS [56] to obtain sam-
ple sizes comparable to the single-cell sets under study
(obtained from the GEUVADIS consortium data browser
at www.ebi.ac.uk/arrayexpress/files/E-GEUV-1/analysis_
results/GD660.GeneQuantCount.txt.gz). Dataset LC con-
sists of 77 normal lung tissue samples from the TCGA
lung adenocarcinoma study [57] (obtained from GEO [55]
using accession number GSE40419). All datasets were
normalized using DESeq normalization [53] except for
LC, for which the authors supplied values already normal-
ized by RPKM.
Mixture model formulation
Dirichlet processmixture of normals
Let Ycg = (ycg1, . . . , ycgJc) be the log-transformed nonzero
expression measurements of gene g for a collection of Jc
cells in condition c out of 2 total conditions. For simplic-
ity of presentation, we drop the dependency on g for now,
and let the total number of cells with nonzero measure-
ments be J . We assume that under the null hypothesis
of equivalent distributions (i.e., no dependency on condi-
tion), Y = {Yc}c=1,2 can be modeled by a conjugate DPM
of normals given by
ycj ∼ N(μj, τj)
μj, τj ∼ G
G ∼ DP(α,G0)
G0 = NG(m0, s0, a0/2, 2/b0)
(1)
where DP is the Dirichlet process with base distribution
G0 and precision parameter α, N(μj, τj) is the normal dis-
tribution parameterized with mean μj and precision τj
(i.e., with variance τ−2j ), and NG(m0, s0, a0/2, 2/b0) is the
normal-gamma distribution with meanm0, precision s0τj,
shape a0/2, and scale 2/b0. Let K denote the number of
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components [unique values among (μ, τ) = {μj, τj}Jj=1].
Note that two observations indexed by j and j′ belong to
the same component if and only if (μj, τj) = (μj′ , τj′).
Product partitionmodels
The posterior distribution of (μ, τ) is intractable even for
moderate sample sizes. This is because the number of pos-
sible partitions (clusterings) of the data grows extremely
rapidly as the sample size increases (according to the Bell
number). However, if we let Z = (z1, . . . , zJ ) be the vec-
tor of component memberships of gene g for all samples,
where the number of unique Z values is K , the proba-
bility density of Y conditional on Z can be viewed as a
PPM [58, 59]. Thus, it can be written as a product over all
component-specific densities:
f (Y |Z) =
K∏
k=1
f (y(k)) (2)
where y(k) is the vector of observations belonging to
component k and f (y(k)) is the component-specific distri-
bution after integrating over all other parameters. In the
conjugate normal-gamma setting, this has a closed form
given by
f (y(k)) ∝ (ak/2)
(bk/2)ak/2
s−1/2k . (3)
The posterior for the parameters (μk , τk) conditional on
the partition is
(μk , τk)|Y ,Z ∼ NG(mk , sk , ak/2, 2/bk). (4)
The posterior parameters (mk , sk , ak , bk) also have a
closed form due to the conjugacy of the model given by
Eq. 1. These parameters are given by
sk = s0 + n(k)
mk = s0m0 +
∑
y(k)
sk
ak = a0 + n(k)
bk = b0 +
∑
(y(k))2 + s0m20 − skm2k
(5)
where n(k) is the number of observations in component
k. It follows that the marginal posterior distribution of μk
conditional on the partition is
μk|Y ,Z ∼ tak
(
mk ,
bk
aksk
)
(6)
where ta(b, c) denotes the generalized Student’s t distribu-
tion with a degrees of freedom, noncentrality parameter b,
and scale parameter c. The product partition DPM model
can be simplified as follows:
yj |zj = k,μk , τk ∼ N(μk , τk)
μk , τk ∼ NG(m0, s0, a0/2, 2/b0)
z ∼ α
K(α)
(α + J)
K∏
k=1
(n(k)).
(7)
Then we can obtain the joint predictive distribution of
the data Y and partition Z by incorporating Eq. 7:
f (Y ,Z) = f (Z)
K∏
k=1
f (y(k))
∝ αK
K∏
k=1
(n(k))(ak/2)
(bk/2)ak/2
s−1/2k .
(8)
Model-fitting
The fitting of the model given in Eq. 7 involves obtain-
ing an estimate Zˆ of the partition. The goal is to find the
partition that yields the highest posterior mass in Eq. 8,
referred to as the maximum a posteriori (MAP) partition
estimate. Under this modeling framework, the solution for
the MAP estimate is not deterministic and several com-
putational procedures have been developed utilizing Polya
urn Gibbs sampling [60–62], agglomerative greedy search
algorithms [63, 64], or an iterative stochastic search [65].
These procedures generally involve evaluation of the
posterior at many different candidate partitions, and as
such tend to be computationally intensive. To avoid this
challenge, we recognize the relation to the corresponding
estimation problem in the finite mixture model frame-
work, where the partition estimate can be obtained by
optimizing the Bayesian information criterion (BIC) of the
marginal density f (Y |Z) [66]. In fact, for certain settings
of the prior distribution over partitions, the MAP esti-
mate is identical to the estimate obtained by optimizing
the BIC [59]. In practice, even when these settings are not
invoked, the performance of partition estimates obtained
via BIC optimization show comparable performance (see
Additional file 1: Section 1). We obtain the partition esti-
mate Zˆ that optimizes the BIC using the Mclust R
package [66] and satisfies the criteria for multi-modality
described in the next section.
The hyperparameters for the component-specific mean
and precision parameters were chosen so as to encode
a heavy-tailed distribution over the parameters. Specifi-
cally, the parameters were set to μ0 = 0, τ 20 = 0.01, a0 =
0.01, and b0 = 0.01. The Dirichlet concentration param-
eter was set to α = 0.01, and choosing this is shown in
Additional file 1: Section 1 to be robust to many different
settings in a sensitivity analysis.
Partition estimation
The partition estimate Zˆ is obtained that optimizes BIC
using Mclust [66], in addition to the following filtering
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criteria. Note that the only constraint imposed on the
number of components K in the modeling framework is
that K ≤ J . However, under the sample sizes in this study,
we consider only K ≤ 5. The first filtering criterion is
based on the notion that a two-component mixture model
is not necessarily bimodal [67], and relaxes the require-
ment that the MAP estimate corresponds to the model
with the lowest BIC. Specifically, for each candidatemodel
fitted by BIC with K components, a split step (if K = 1,
obtain a new partition estimate Zˆ with K = 2 unique
elements) or a merge step (if K ≥ 2, obtain a new par-
tition estimate Zˆ restricted to K − 1 unique elements)
is carried out to generate a new candidate partition. The
candidate partition with the larger value of K becomes the
partition estimate only if the component separation sug-
gests multi-modality. Component separation between any
pair of components is assessed with the bimodality index
(BI) [68]:
BI = 2 ×
√ n1n2
(n1 + n2)2
( |μ1 − μ2|
σ
)
where the component means μ1 and μ2 are estimated
via maximum likelihood, the common within-component
standard deviation σ is conservatively estimated with the
maximum within-component standard deviation among
all components, and n1 and n2 are the number of cells
belonging to each component. BI thresholds for the split
and merge step were determined empirically and vary by
sample size, as multiple modes are more easily detected as
sample size increases [68] (for more details see Additional
file 1: Section 4).
The second filtering criterion is designed to reduce
the impact of outlier cells. Specifically, components with
fewer than three cells are not considered, and the merge
step is also carried out if one of the components present
has an extremely large variance compared to the others
(more than 20 times larger than any other component).
Likewise, the split step is not carried out if one of the
proposed components has a variance more than 10 times
larger than any other component.
Simulation details
Componentmeans and variances
Each gene was simulated based on the characteristics of
a randomly sampled unimodal gene with at least 25%
nonzero measurements in the H1 dataset. For unimodal
genes, the mean and variance were chosen to match the
observed mean and variance; for bimodal genes, the com-
ponent means and variances were selected to be near the
observed mean and variance. The proportion of zeroes is
chosen to match that observed in the randomly sampled
gene, and is not varied by condition. Details are provided
in the following sections.
Distances between (log-scale) component means μσ
in the multi-modal genes were chosen such that com-
ponents were separated by a minimum of two and a
maximum of six standard deviations, where the stan-
dard deviation σ is assumed constant (on the log-scale)
across components. The specific values of σ used for the
simulated genes are empirical estimates of the standard
deviations of the unimodal case study genes (assuming
a lognormal distribution on the raw scale). In this set-
ting, the component distance can also be thought of
as a fold-change within condition (across components),
where the ratio of the component means (untransformed-
scale) is equal to eμσˆ . The ratio of the component
standard deviations (raw scale) is also equal to this
same fold-change (see Additional file 1: Section 2.1 for
more details). The component mean distance values were
chosen to represent a range of settings for which the
difficulty of detecting multi-modality is widely varied,
as well as to reflect the range of observed compo-
nent mean distances detected empirically in the case
studies.
Unimodal genes
The parameters of the negative binomial distribution for
unimodal genes were estimated from the randomly sam-
pled observed genes using the method of moments. These
empirical parameters were used as is to simulate both
conditions of EE genes, and condition 1 of DE and DB.
Condition 1 of DMwas simulated by decreasing the mean
by half the value ofμ. The second condition for DE genes
was simulated based on condition 1 parameters using ran-
domly sampled fold-changes that were between two and
three standard deviations of the observed fold-changes
between H1 and DEC.
Bimodal genes
The parameters for the mixture of negative binomial dis-
tributions in bimodal genes were also generated using
empirically estimated means and variances. The first
(lower) component mean was decreased by half the value
of μ and the second (higher) component mean was
increased by half the value of μ.
DD classification algorithm
Genes detected as significantly DD from the permuta-
tion test of the Bayes factor score are categorized into
patterns of interest. The genes that are not classified
as DE, DP, DM, or DB are considered to be no calls,
abbreviated NC. These represent patterns that are not of
primary interest, such as those that differ only in vari-
ance (but not in the number of components or their
means). This type of difference may result from cell-
specific differences in technical variation [17], which
can only be decomposed from biological variation in
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experimental protocols that allow for independent esti-
mation of technical effects using spike-in controls, for
example [69].
An additional step to improve the power to detect genes
in the DP category was also implemented. This step was
motivated by the observation that the Bayes factor score
tends to be small when the clustering process within each
condition is consistent with that overall, as in the case of
DP. Thus, for genes that were not significantly DD by per-
mutation but had the same number of components within
condition as overall, Fisher’s exact test was used to test
for independence with biological condition. If the p value
for that test is less than 0.05, then the gene was added to
the DP category (this did not result in the addition of any
false positives in the simulation study). In addition, since
the Bayes factor score depends on the estimated parti-
tion, we increase the robustness of the approach to detect
DD genes under possible misspecification of the parti-
tion by also assessing evidence of DD in the form of an
overall mean shift for genes not significant by the per-
mutation test (using a t-statistic with FDR controlled by
[35]). This resulted in the detection of between 121 and
689 additional genes in the hESC comparisons and did not
add any false positives in 94% of simulation replications
(with only a single false positive gene in the other 6% of
replications).
Here we present pseudocode for the classification
of DD genes into the categories DE, DP, DM, or
DB. For every pair of components, we obtain a sam-
ple of 10,000 observations from the posterior distri-
bution of the difference in means. The components
are considered to overlap if the 100% credible interval
contains 0.
DD classification algorithm
if c1 = c2 = 1
if components c1 and c2 do not overlap ⇒ DE
else ⇒ NC
else if c1 = c2 ≥ 2
if c1 = c2 = cOA
if At least c1 of the components overlap ⇒ DP
else ⇒ NC
else if c1 = c2 < cOA
if at most one component pair overlaps ⇒ DE
else ⇒ NC
else if c1 	= c2
if no components pairs overlap ⇒ DB
else ⇒ DM
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